J. Exp. Med.
Volume 185, Number 6, March 17, 1997 1113-1122

An HLA-DR1 Transgene Confers Susceptibility to Collagen-induced Arthritis Elicited with Human Type II Collagen

By Edward F. Rosloniec,^§¶ David D. Brand,^§¶ Linda K. Myers, Karen B. Whittington,^¶ Marina Gumanovskaya,^§ Dennis M. Zaller,^* Andrea Woods,^* Daniel M. Altmann, John M. Stuart,^§¶ and Andrew H. Kang^§¶

From the ^* Department of Molecular Immunology, Merck Research Laboratories, Rahway, New Jersey 07065;  Department of Transplantation Biology, Medical Research Council Clinical Sciences Centre, Royal Postgraduate Medical School, Hammersmith Hospital, London W12 ONN, United Kingdom; the ^§ Department of Medicine, the  Department of Pediatrics, University of Tennessee, Memphis, Tennessee 38163; and the ^¶ Veterans Affairs Medical Center, Memphis, Tennessee 38104

Rheumatoid arthritis (RA) is an autoimmune disease that is strongly associated with the expression of several HLA-DR haplotypes, including DR1 (DRB1*0101). Although the antigen that initiates RA remains elusive, it has been shown that many patients have autoimmunity directed to type II collagen (CII). To test the hypothesis that HLA-DR1 is capable of mediating an immune response to CII, we have generated transgenic mice expressing chimeric (human/ mouse) HLA-DR1. When the DR1 transgenic mice were immunized with human CII (hCII), they developed a severe autoimmune arthritis, evidenced by severe swelling and erythema of the limbs and marked inflammation and erosion of articular joints. The development of the autoimmune arthritis was accompanied by strong DR1-restricted T and B cell responses to hCII. The T cell response was focused on a dominant determinant contained within CII(259-273) from which an eight amino acid core was defined. The B cell response was characterized by high titers of antibody specific for hCII, and a high degree of cross-reactivity with murine type II collagen. These data demonstrate that HLA-DR1 is capable of presenting peptides derived from hCII, and suggest that this DR1 transgenic model will be useful in the development of DR1-specific therapies for RA.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Salazar, L, Aravena, O, Abello, P, Escobar, A, Contreras-Levicoy, J, Rojas-Colonelli, N, Catalan, D, Aguirre, A, Zuniga, R, Pesce, B, Gonzalez, C, Cepeda, R, Cuchacovich, M, Molina, M C, Salazar-Onfray, F, Delgado, M, Toes, R E, Aguillon, J C (2008). Modulation of established murine collagen-induced arthritis by a single inoculation of short-term lipopolysaccharide-stimulated dendritic cells. Ann Rheum Dis 67: 1235-1241 [Abstract] [Full Text]  
• Huan, J., Kaler, L. J., Mooney, J. L., Subramanian, S., Hopke, C., Vandenbark, A. A., Rosloniec, E. F., Burrows, G. G., Offner, H. (2008). MHC Class II Derived Recombinant T Cell Receptor Ligands Protect DBA/1LacJ Mice from Collagen-Induced Arthritis. J. Immunol. 180: 1249-1257 [Abstract] [Full Text]  
• Ling, S., Pi, X., Holoshitz, J. (2007). The Rheumatoid Arthritis Shared Epitope Triggers Innate Immune Signaling via Cell Surface Calreticulin. J. Immunol. 179: 6359-6367 [Abstract] [Full Text]  
• Hultqvist, M., Backlund, J., Bauer, K., Gelderman, K. A., Holmdahl, R. (2007). Lack of Reactive Oxygen Species Breaks T Cell Tolerance to Collagen Type II and Allows Development of Arthritis in Mice. J. Immunol. 179: 1431-1437 [Abstract] [Full Text]  
• von Delwig, A., Altmann, D. M, Charlton, F. G, McKie, N., Isaacs, J. D, Holmdahl, R., Robinson, J. H (2007). T cell responses to a non-glycosylated epitope predominate in type II collagen-immunised HLA-DRB1*0101 transgenic mice. Ann Rheum Dis 66: 599-604 [Abstract] [Full Text]  
• Hopner, S., Dickhaut, K., Hofstatter, M., Kramer, H., Ruckerl, D., Soderhall, J. A., Gupta, S., Marin-Esteban, V., Kuhne, R., Freund, C., Jung, G., Falk, K., Rotzschke, O. (2006). Small Organic Compounds Enhance Antigen Loading of Class II Major Histocompatibility Complex Proteins by Targeting the Polymorphic P1 Pocket. J. Biol. Chem. 281: 38535-38542 [Abstract] [Full Text]  
• Rosloniec, E. F., Ivey, R. A. III, Whittington, K. B., Kang, A. H., Park, H.-W. (2006). Crystallographic Structure of a Rheumatoid Arthritis MHC Susceptibility Allele, HLA-DR1 (DRB1*0101), Complexed with the Immunodominant Determinant of Human Type II Collagen. J. Immunol. 177: 3884-3892 [Abstract] [Full Text]  
• Dzhambazov, B., Nandakumar, K. S., Kihlberg, J., Fugger, L., Holmdahl, R., Vestberg, M. (2006). Therapeutic Vaccination of Active Arthritis with a Glycosylated Collagen Type II Peptide in Complex with MHC Class II Molecules. J. Immunol. 176: 1525-1533 [Abstract] [Full Text]  
• Li, H., Van Vranken, S., Zhao, Y., Li, Z., Guo, Y., Eisele, L., Li, Y. (2005). Crystal structures of T cell receptor {beta} chains related to rheumatoid arthritis. Protein Sci. 14: 3025-3038 [Abstract] [Full Text]  
• Latham, K. A., Whittington, K. B., Zhou, R., Qian, Z., Rosloniec, E. F. (2005). Ex Vivo Characterization of the Autoimmune T Cell Response in the HLA-DR1 Mouse Model of Collagen-Induced Arthritis Reveals Long-Term Activation of Type II Collagen-Specific Cells and Their Presence in Arthritic Joints. J. Immunol. 174: 3978-3985 [Abstract] [Full Text]  
• Yamada, H., Dzhambazov, B., Bockermann, R., Blom, T., Holmdahl, R. (2004). A Transient Post-Translationally Modified Form of Cartilage Type II Collagen Is Ignored by Self-Reactive T Cells. J. Immunol. 173: 4729-4735 [Abstract] [Full Text]  
• Cremer, M. A., Ye, X. J., Myers, L. K., Brand, D. D., Rosloniec, E. F., Kang, A. H. (2004). T Cell Immunity to Type II Collagen in the Biobreeding Rat: The Identification and Characterization of RT1u-Restricted T Cell Epitopes on {alpha}1(II). J. Immunol. 173: 1795-1801 [Abstract] [Full Text]  
• Mirshahidi, S., Ferris, L. C. K., Sadegh-Nasseri, S. (2004). The Magnitude of TCR Engagement Is a Critical Predictor of T Cell Anergy or Activation. J. Immunol. 172: 5346-5355 [Abstract] [Full Text]  
• Backlund, J., Nandakumar, K. S., Bockermann, R., Mori, L., Holmdahl, R. (2003). Genetic Control of Tolerance to Type II Collagen and Development of Arthritis in an Autologous Collagen-Induced Arthritis Model. J. Immunol. 171: 3493-3499 [Abstract] [Full Text]  
• Rajagopalan, G., Kudva, Y. C., Chen, L., Wen, L., David, C. S. (2003). Autoimmune diabetes in HLA-DR3/DQ8 transgenic mice expressing the co-stimulatory molecule B7-1 in the {beta} cells of islets of Langerhans. Int Immunol 15: 1035-1044 [Abstract] [Full Text]  
• Gehring, A. J., Rojas, R. E., Canaday, D. H., Lakey, D. L., Harding, C. V., Boom, W. H. (2003). The Mycobacterium tuberculosis 19-Kilodalton Lipoprotein Inhibits Gamma Interferon-Regulated HLA-DR and Fc{gamma}R1 on Human Macrophages through Toll-Like Receptor 2. Infect. Immun. 71: 4487-4497 [Abstract] [Full Text]  
• Leonard, E. G., Canaday, D. H., Harding, C. V., Schreiber, J. R. (2003). Antigen Processing of the Heptavalent Pneumococcal Conjugate Vaccine Carrier Protein CRM197 Differs Depending on the Serotype of the Attached Polysaccharide. Infect. Immun. 71: 4186-4189 [Abstract] [Full Text]  
• Tsark, E. C., Wang, W., Teng, Y.-C., Arkfeld, D., Dodge, G. R., Kovats, S. (2002). Differential MHC Class II-Mediated Presentation of Rheumatoid Arthritis Autoantigens by Human Dendritic Cells and Macrophages. J. Immunol. 169: 6625-6633 [Abstract] [Full Text]  
• La Rosa, C., Wang, Z., Brewer, J. C., Lacey, S. F., Villacres, M. C., Sharan, R., Krishnan, R., Crooks, M., Markel, S., Maas, R., Diamond, D. J. (2002). Preclinical development of an adjuvant-free peptide vaccine with activity against CMV pp65 in HLA transgenic mice. Blood 100: 3681-3689 [Abstract] [Full Text]  
• Backlund, J., Carlsen, S., Hoger, T., Holm, B., Fugger, L., Kihlberg, J., Burkhardt, H., Holmdahl, R. (2002). Predominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 99: 9960-9965 [Abstract] [Full Text]  
• Rosloniec, E. F., Whittington, K. B., Zaller, D. M., Kang, A. H. (2002). HLA-DR1 (DRB1*0101) and DR4 (DRB1*0401) Use the Same Anchor Residues for Binding an Immunodominant Peptide Derived from Human Type II Collagen. J. Immunol. 168: 253-259 [Abstract] [Full Text]  
• Brand, D. D., Myers, L. K., Whittington, K. B., Latham, K. A., Stuart, J. M., Kang, A. H., Rosloniec, E. F. (2002). Detection of Early Changes in Autoimmune T Cell Phenotype and Function Following Intravenous Administration of Type II Collagen in a TCR-Transgenic Model. J. Immunol. 168: 490-498 [Abstract] [Full Text]  
• Mirshahidi, S., Huang, C.-T., Sadegh-Nasseri, S. (2001). Anergy in Peripheral Memory CD4+ T Cells Induced by Low Avidity Engagement of T Cell Receptor. J. Exp. Med. 194: 719-732 [Abstract] [Full Text]  
• Corrigall, V. M., Bodman-Smith, M. D., Fife, M. S., Canas, B., Myers, L. K., Wooley, P. H., Soh, C., Staines, N. A., Pappin, D. J. C., Berlo, S. E., van Eden, W., van der Zee, R., Lanchbury, J. S., Panayi, G. S. (2001). The Human Endoplasmic Reticulum Molecular Chaperone BiP Is an Autoantigen for Rheumatoid Arthritis and Prevents the Induction of Experimental Arthritis. J. Immunol. 166: 1492-1498 [Abstract] [Full Text]  
• Fontenot, A. P., Torres, M., Marshall, W. H., Newman, L. S., Kotzin, B. L. (2000). Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease. Proc. Natl. Acad. Sci. USA 10.1073/pnas.220430797v1 [Abstract] [Full Text]  
• Kotzin, B. L., Falta, M. T., Crawford, F., Rosloniec, E. F., Bill, J., Marrack, P., Kappler, J. (2000). Use of soluble peptide-DR4 tetramers to detect synovial T cells specific for cartilage antigens in patients with rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 97: 291-296 [Abstract] [Full Text]  
• Madsen, L., Labrecque, N., Engberg, J., Dierich, A., Svejgaard, A., Benoist, C., Mathis, D., Fugger, L. (1999). Mice lacking all conventional MHC class II genes. Proc. Natl. Acad. Sci. USA 96: 10338-10343 [Abstract] [Full Text]  
• Smith, K. J., Pyrdol, J., Gauthier, L., Wiley, D. C., Wucherpfennig, K. W. (1998). Crystal Structure of HLA-DR2 (DRA*0101, DRB1*1501) Complexed with a Peptide from Human Myelin Basic Protein. J. Exp. Med. 188: 1511-1520 [Abstract] [Full Text]  
• Fridkis-Hareli, M., Rosloniec, E. F., Fugger, L., Strominger, J. L. (1998). Synthetic amino acid copolymers that bind to HLA-DR proteins and inhibit type II collagen-reactive T cell clones. Proc. Natl. Acad. Sci. USA 95: 12528-12531 [Abstract] [Full Text]  
• Geluk, A., Taneja, V., van Meijgaarden, K. E., Zanelli, E., Abou-Zeid, C., Thole, J. E. R., de Vries, R. R. P., David, C. S., Ottenhoff, T. H. M. (1998). Identification of HLA class II-restricted determinants of Mycobacterium tuberculosis-derived proteins by using HLA-transgenic, class II-deficient mice. Proc. Natl. Acad. Sci. USA 95: 10797-10802 [Abstract] [Full Text]  
• Andersson, E. C., Hansen, B. E., Jacobsen, H., Madsen, L. S., Andersen, C. B., Engberg, J., Rothbard, J. B., McDevitt, G. S., Malmstrom, V., Holmdahl, R., Svejgaard, A., Fugger, L. (1998). Definition of MHC and T cell receptor contacts in the HLA-DR4restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice. Proc. Natl. Acad. Sci. USA 95: 7574-7579 [Abstract] [Full Text]  
• Rosloniec1, E. F., Brand, D. D., Myers, L. K., Esaki, Y., Whittington, K. B., Zaller, D. M., Woods, A., Stuart, J. M., Kang, A. H. (1998). Induction of Autoimmune Arthritis in HLA-DR4 (DRB1*0401) Transgenic Mice by Immunization with Human and Bovine Type II Collagen. J. Immunol. 160: 2573-2578 [Abstract] [Full Text]  
• Fontenot, A. P., Torres, M., Marshall, W. H., Newman, L. S., Kotzin, B. L. (2000). Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease. Proc. Natl. Acad. Sci. USA 97: 12717-12722 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS